Found: 37
Select item for more details and to access through your institution.
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.
- Published in:
- Journal of Pathology, 2024, v. 263, n. 3, p. 360, doi. 10.1002/path.6289
- By:
- Publication type:
- Article
SOX11 promotes invasive growth and ductal carcinoma in situ progression.
- Published in:
- Journal of Pathology, 2017, v. 243, n. 2, p. 193, doi. 10.1002/path.4939
- By:
- Publication type:
- Article
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 731, doi. 10.1007/s10549-019-05134-x
- By:
- Publication type:
- Article
MSI-low, a real phenomenon which varies in frequency among cancer types.
- Published in:
- Journal of Pathology, 2003, v. 201, n. 3, p. 389, doi. 10.1002/path.1453
- By:
- Publication type:
- Article
Expression of IGF-I and IGF-II in phyllodes tumours and fibroadenomas.
- Published in:
- Journal of Pathology, 2003, v. 200, n. 5, p. 627, doi. 10.1002/path.1391
- By:
- Publication type:
- Article
Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
- Published in:
- Journal of Pathology, 2003, v. 200, n. 1, p. 59, doi. 10.1002/path.1318
- By:
- Publication type:
- Article
The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
- Published in:
- Journal of Pathology, 2002, v. 196, n. 4, p. 437, doi. 10.1002/path.1067
- By:
- Publication type:
- Article
Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0130598
- By:
- Publication type:
- Article
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
- Published in:
- Human Genetics, 2016, v. 135, n. 1, p. 137, doi. 10.1007/s00439-015-1616-8
- By:
- Publication type:
- Article
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41523-020-00202-8
- By:
- Publication type:
- Article
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4397, doi. 10.3390/cancers15174397
- By:
- Publication type:
- Article
Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3036, doi. 10.3390/cancers13123036
- By:
- Publication type:
- Article
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 2, p. 437, doi. 10.1007/s10549-009-0395-0
- By:
- Publication type:
- Article
Low penetrance breast cancer predisposition SNPs are site specific.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 117, n. 1, p. 151, doi. 10.1007/s10549-008-0235-7
- By:
- Publication type:
- Article
Common genetic susceptibility to DCIS and invasive ductal carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
- Published in:
- Cancer Imaging, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s40644-024-00691-x
- By:
- Publication type:
- Article
Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
- Published in:
- Cancer Imaging, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s40644-024-00691-x
- By:
- Publication type:
- Article
Development of a deep‐learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2‐low cases.
- Published in:
- Histopathology, 2024, v. 85, n. 3, p. 478, doi. 10.1111/his.15274
- By:
- Publication type:
- Article
MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 2, p. 277, doi. 10.1038/bjc.2017.450
- By:
- Publication type:
- Article
MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0160316
- By:
- Publication type:
- Article
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 1, p. 171, doi. 10.1038/s41416-024-02697-5
- By:
- Publication type:
- Article
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1828, doi. 10.1038/s41416-024-02679-7
- By:
- Publication type:
- Article
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 12, p. 2125, doi. 10.1038/s41416-022-01983-4
- By:
- Publication type:
- Article
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project.
- Published in:
- 2021
- By:
- Publication type:
- journal article
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
- Published in:
- Health Technology Assessment, 2023, v. 27, n. 25/26, p. vii, doi. 10.3310/WWBF1044
- By:
- Publication type:
- Article
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
- Published in:
- Journal of Pathology: Clinical Research, 2015, v. 1, n. 1, p. 18, doi. 10.1002/cjp2.3
- By:
- Publication type:
- Article
Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS).
- Published in:
- Acta Oncologica, 2023, v. 62, n. 9, p. 1045, doi. 10.1080/0284186X.2023.2245552
- By:
- Publication type:
- Article
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 4, p. 1, doi. 10.1371/journal.pgen.1004285
- By:
- Publication type:
- Article
11q13 is a susceptibility locus for hormone receptor positive breast cancer.
- Published in:
- Human Mutation, 2012, v. 33, n. 7, p. 1123, doi. 10.1002/humu.22089
- By:
- Publication type:
- Article
Reporting on invasive lobular breast cancer in clinical trials: a systematic review.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00627-5
- By:
- Publication type:
- Article
CYP3A Variation, Premenopausal Estrone Levels, and Breast Cancer Risk.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 9, p. 657, doi. 10.1093/jnci/djs156
- By:
- Publication type:
- Article